Welsh KJ, Kirkman MS, Sacks DB. Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions. Diabetes Care. 2016;39(8):1299–306. https://doi.org/10.2337/dc15-2727.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Selvin E. Hemoglobin A(1c)-Using epidemiology to guide medical practice: Kelly West Award Lecture 2020. Diabetes Care. 2021. https://doi.org/10.2337/dci21-0035.

Article  PubMed  PubMed Central  Google Scholar 

McAlister FA, Zheng Y, Westerhout CM, Buse JB, Standl E, McGuire DK, Van de Werf F, Green JB, Armstrong PW, Holman RR. Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial. Eur J Heart Fail. 2020;22(11):2026–34. https://doi.org/10.1002/ejhf.1958.

Article  CAS  PubMed  Google Scholar 

Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up. Diabetes Care. 2016;39(5):686–93. https://doi.org/10.2337/dc15-1990.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England) 1998;352(9131):837–53.

Segar MW, Patel KV, Vaduganathan M, Caughey MC, Butler J, Fonarow GC, Grodin JL, McGuire DK, Pandey A. Association of long-term change and variability in glycemia with risk of incident heart failure among patients with type 2 diabetes: A secondary analysis of the ACCORD trial. Diabetes Care. 2020;43(8):1920–8. https://doi.org/10.2337/dc19-2541.

Article  PubMed  PubMed Central  Google Scholar 

Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473–8. https://doi.org/10.2337/dc08-0545.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng JM, Cooke M, Bhandari S, Atkin SL, Kilpatrick ES. The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease. Diabetes Care. 2010;33(11):2310–3. https://doi.org/10.2337/dc10-0917.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M, Shino T, Yamada C, Nagaoka Y. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Internal medicine (Tokyo, Japan). 1998;37(10):826–30. https://doi.org/10.2169/internalmedicine.37.826.

Article  CAS  PubMed  Google Scholar 

English E, Idris I, Smith G, Dhatariya K, Kilpatrick ES, John WG. The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review. Diabetologia. 2015;58(7):1409–21. https://doi.org/10.1007/s00125-015-3599-3.

Article  CAS  PubMed  Google Scholar 

Zelnick LR, Batacchi ZO, Ahmad I, Dighe A, Little RR, Trence DL, Hirsch IB, de Boer IH. Continuous glucose monitoring and use of alternative markers to assess glycemia in chronic kidney disease. Diabetes Care. 2020;43(10):2379–87. https://doi.org/10.2337/dc20-0915.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D, Haliassos A. Relationship between mean blood glucose and glycated haemoglobin in type 2 diabetic patients. Diabet Med. 2008;25(2):174–8. https://doi.org/10.1111/j.1464-5491.2007.02379.x.

Article  CAS  Google Scholar 

Wilson DM, Xing D, Beck RW, Block J, Bode B, Fox LA, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Steffes M, Tamborlane WV. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care. 2011;34(3):540–4. https://doi.org/10.2337/dc10-1054.

Article  CAS  Google Scholar 

Lo C, Lui M, Ranasinha S, Teede HJ, Kerr PG, Polkinghorne KR, Nathan DM, Zheng H, Zoungas S. Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease. Diabetes Res Clin Pract. 2014;104(1):84–91. https://doi.org/10.1016/j.diabres.2014.01.020.

Article  CAS  Google Scholar 

Rognant N, Lemoine S, Laville M, Hadj-Aïssa A, Dubourg L. Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients. Diabetes Care. 2011;34(6):1320–2. https://doi.org/10.2337/dc11-0203.

Article  PubMed  PubMed Central  Google Scholar 

Ahrén B, Foley JE. Estimation of the relative contribution of postprandial glucose exposure to average total glucose exposure in subjects with type 2 diabetes. Int J Endocrinol. 2016;2016:3452898. https://doi.org/10.1155/2016/3452898.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aleppo G, Webb K. Continuous glucose monitoring integration in clinical practice: a stepped guide to data review and interpretation. J Diabetes Sci Technol. 2019;13(4):664–73. https://doi.org/10.1177/1932296818813581.

Article  PubMed  Google Scholar 

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631–40. https://doi.org/10.2337/dc17-1600.

Article  PubMed Central  Google Scholar 

Munshi MN, Segal AR, Slyne C, Samur AA, Brooks KM, Horton ES. Shortfalls of the use of HbA1C-derived eAG in older adults with diabetes. Diabetes Res Clin Pract. 2015;110(1):60–5. https://doi.org/10.1016/j.diabres.2015.07.012.

Article  CAS  Google Scholar 

Hu Y, Shen Y, Yan R, Li F, Ding B, Wang H, Su X, Ma J. Relationship between estimated glycosylated hemoglobin using flash glucose monitoring and actual measured glycosylated hemoglobin in a Chinese population. Diabetes Ther. 2020;11(9):2019–27. https://doi.org/10.1007/s13300-020-00879-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hempe JM, Soros AA, Chalew SA. Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic control. Diabetes Care. 2010;33(7):1449–51. https://doi.org/10.2337/dc09-1498.

Article  CAS  PubMed Central  Google Scholar 

Wright AK, Welsh P, Gill JMR, Kontopantelis E, Emsley R, Buchan I, Ashcroft DM, Rutter MK, Sattar N. Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA(1c) and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia. 2020;63(8):1542–53. https://doi.org/10.1007/s00125-020-05169-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergenstal RM, Gal RL, Connor CG, Gubitosi-Klug R, Kruger D, Olson BA, Willi SM, Aleppo G, Weinstock RS, Wood J, Rickels M, DiMeglio LA, Bethin KE, Marcovina S, Tassopoulos A, Lee S, Massaro E, Bzdick S, Ichihara B, Markmann E, McGuigan P, Woerner S, Ecker M, Beck RW. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann Intern Med. 2017;167(2):95–102. https://doi.org/10.7326/m16-2596.

Article  PubMed  Google Scholar 

Flückiger R, Harmon W, Meier W, Loo S, Gabbay KH. Hemoglobin carbamylation in uremia. N Engl J Med. 1981;304(14):823–7. https://doi.org/10.1056/nejm198104023041406.

Article  PubMed  Google Scholar 

Selvin E, Sacks DB. Monitoring glycemic control in end-stage renal disease: what should be measured? Clin Chem. 2017;63(2):447–9. https://doi.org/10.1373/clinchem.2016.265744.

Article  CAS  PubMed  Google Scholar 

Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112(3):126–8. https://doi.org/10.1159/000079722.

Article  CAS  PubMed  Google Scholar 

Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25(2):275–8. https://doi.org/10.2337/diacare.25.2.275.

Article  CAS  PubMed  Google Scholar 

Hoshino J, Molnar MZ, Yamagata K, Ubara Y, Takaichi K, Kovesdy CP, Kalantar-Zadeh K. Developing an HbA(1c)-based equation to estimate blood glucose in maintenance hemodialysis patients. Diabetes Care. 2013;36(4):922–7. https://doi.org/10.2337/dc12-1019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao C, Luo Q, He F, Peng F, Xia X, Huang F, Yu X. Establishing HbA1c -mean blood glucose formulae for patients on continuous ambulatory peritoneal dialysis. Diabet Med. 2014;31(7):813–20. https://doi.org/10.1111/dme.12432.

Article  CAS  PubMed  Google Scholar 

Bailey R, Calhoun P, Bergenstal RM, Beck RW. Assessment of the glucose management indicator using different sampling durations. Diabetes Technol Ther. 2023;25(2):148–50. https://doi.org/10.1089/dia.2022.0284.

Article  CAS  Google Scholar